Roche (RHHBY) Holding plans to test if an experimental medicine can prevent symptoms of Alzheimer’s disease, AD, in people that are high-risk, Naomi Kresge of Bloomberg reports. The late-stage study will specifically focus on individuals are risk of cognitive decline, with the goal to slow down the emergence of or completely prevent symptoms.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY: